articleJournal of Clinical OncologyJul 1, 2014GREEN OA

Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

Dana-Farber/Harvard Cancer Center · Novartis (United States)

PubMed
Indexed incrossrefpubmed

Abstract

In a longitudinal clinical study to compare two groups, the primary end point is often the time to a specific event (eg, disease progression, death). The hazard ratio estimate is routinely used to empirically quantify the between-group difference under the assumption that the ratio of the two hazard functions is approximately constant over time. When this assumption is plausible, such a ratio estimate may capture the relative difference between two survival curves. However, the clinical meaning of such a ratio estimate is difficult, if not impossible, to interpret when the underlying proportional hazards assumption is violated (ie, the hazard ratio is not constant over time). Although this issue has been…

Citation impact

766
total citations
FWCI
29.22
Percentile
100%
References
28
Citations per year

Authors

16

Topics & keywords

Keywords
  • Hazard ratio
  • Hazard
  • Statistics
  • Medicine
  • Estimator
  • Event (particle physics)
  • Econometrics
  • Proportional hazards model
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding